Sun Pharma reports a higher profit for the first quarter, with consolidated net profit rising 27% to ₹2,895 crore. The company posts the increase against ₹2,279 crore in the same quarter a year earlier. The rise is attributed to stronger demand for the company’s products, according to one outlet. Another report highlights the net profit figure and the year-on-year comparison. Together, the sources describe a consistent set of results: a Q1 increase in consolidated net profit to ₹2,895 crore, with growth measured at 27% year over year from ₹2,279 crore. One report also provides a dollar-equivalent figure of $303.54 million for the quarter’s net profit. The coverage centers on the company’s quarterly earnings performance and does not add further details such as segment-wise performance, revenue figures, or outlook.